NMN for Frailty: What the Evidence Actually Shows
What is Frailty?
Frailty is a syndrome of reduced physiological reserve in older adults, marked by exhaustion, slow gait, weak grip and unintentional weight loss. It predicts hospitalisation and mortality.
NMN relevance: the published evidence
Igarashi 2022 in older Japanese men touches frailty-adjacent endpoints (gait speed, grip) and reported modest gains at 250 mg/day. No trial has used a formal frailty index as the primary outcome. Exercise plus protein remains first-line.
Questions to ask before supplementing
250 mg/day per Igarashi 2022 in similar populations.
Contraindications and red flags
Comprehensive geriatric assessment should precede supplement use.
Bottom line for Malaysian patients
NMN is not registered with NPRA as a treatment for any specific condition; it is sold as a general health supplement. If you have frailty, use this page as a question list for a registered medical practitioner before adding NMN to existing therapy. Read our safety guide for full red-flag context.
Related conditions
- Sarcopenia - Sarcopenia is the age-related loss of muscle mass, strength and function. It increases falls, disabi...
- Biological Aging - Biological aging refers to the gradual decline in cellular and organ function that accompanies chron...
- Age-Related Fatigue - Age-related fatigue is persistent low energy and reduced exercise tolerance that comes with ageing, ...
- Osteoporosis - Osteoporosis is reduced bone density that raises fracture risk, especially of the hip, spine and wri...